U.S. Department of Labor Issues Final Rule Requiring PBM Fee Transparency
The U.S. Department of Labor (DOL) has announced a landmark final rule requiring pharmacy benefit managers (PBMs) to disclose detailed information regarding their compensation and payment deals with pharmacies and drugmakers. This regulation specifically targets self-insured employer-sponsored health plans, affecting approximately 136 million Americans. The rule aims to curb PBM profiteering by mandating transparency around drug rebates, spread pricing, and other forms of compensation that have historically obscured the true cost of prescription drugs. Under the new mandate, employers gain significant oversight capabilities, including the right to conduct annual audits of PBM disclosures using full transaction-level data rather than limited samples. The DOL also clarified that third-party administrators (TPAs) and other service providers are subject to similar disclosure obligations under ERISA. This move is expected to provide employers with greater leverage to negotiate drug costs and combat rising pharmacy expenditures, which are projected to account for 27% of employer healthcare spending by 2027.
Topics: Department of Labor Rule Drug Pricing Transparency Healthcare Reform Pharmacy Benefit Managers
Read the full article at PR Newswire
Part of the story U.S. Department of Labor Issues Final Rule Requiring PBM Fee Transparency (2 articles)